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In Brief
Allen et al. show that the INI1/hSNF5/
SMARCB1 subunit of the human SWI/
SNF chromatin-remodeling complex
contains a variant winged helix DNA
binding domain. Mutations in INI1 that
cause the tumor-predisposing syndrome
schwannomatosis perturb the fold or
disrupt the function of this domain.
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SWI/SNF complexes use the energy of ATP hydroly-
sis to remodel chromatin. In mammals they play a
central role in regulating gene expression during
differentiation and proliferation. Mutations in SWI/
SNF subunits are among the most frequent gene al-
terations in cancer. The INI1/hSNF5/SMARCB1 sub-
unit is mutated in both malignant rhabdoid tumor, a
highly aggressive childhood cancer, and schwanno-
matosis, a tumor-predisposing syndrome character-
ized by mostly benign tumors of the CNS. Here, we
show that mutations in INI1 that cause schwannoma-
tosis target a hitherto unidentified N-terminal winged
helix DNA binding domain that is also present in the
BAF45a/PHF10 subunit of the SWI/SNF complex.
The domain is structurally related to the SKI/SNO/
DACdomain, which is found in a number ofmetazoan
chromatin-associated proteins.
INTRODUCTION
Enzymes that use the energy of ATP hydrolysis to remodel chro-
matin play a central role in regulating eukaryotic gene expression
(Narlikar et al., 2013). SWI/SNF chromatin-remodeling com-
plexes were first identified in yeast, but have subsequently
been found in all eukaryotic linages. In mammals SWI/SNF-like
complexes bind numerous promoters and enhancers, and con-
trol the expression of many of the genes that regulate cell growth
and differentiation (Tolstorukov et al., 2013). Human SWI/SNF-
like complexes consist of invariant core subunits, which are
conserved in yeast, as well as a number of tissue-specific sub-
units, many of which are unique to metazoa (Euskirchen et al.,
2012). A wide range of different complexes can be formed, which
are generally divided into BAF variants that contain ARID1A or
ARID1B, or PBAF variants, which contain ARID2 (BAF200),
PBRM1 (BAF180), and BRD7. Changes in subunit composition
often accompanies cell differentiation, with particular sets of
subunits being required for stem cell self-renewal and prolifera-
tion, and others being associated with differentiated post-mitotic
tissues. Mutations in SWI/SNF subunits are frequently associ-
ated with cancer (Masliah-Planchon et al., 2015). For example,1344 Structure 23, 1344–1349, July 7, 2015 ª2015 The Authorsgermline alterations (mutations or deletions) of the gene coding
for INI1 (also referred to as hSNF5 due to its similarity to the yeast
protein SNF5, SMARCB1, or BAF47), one of the core subunits of
the complex, predispose individuals to rhabdoid tumors, highly
aggressive cancers primarily affecting young children (Versteege
et al., 1998). Mutations in the INI1 gene also cause the tumor
suppressor syndrome schwannomatosis, which is characterized
by mostly benign tumors of the CNS that typically develop in the
second or third decade of life (Hulsebos et al., 2007). Rhabdoid
tumors are caused by either deletion of the INI1 gene, nonsense
mutations, or frameshift mutations that introduce a novel stop
codon. Mutations within the INI1 gene that are linked to schwan-
nomatosis, in contrast, are missensemutations and in-frame de-
letions affecting residues in the N-terminal portion of the protein
(Bacci et al., 2010; Christiaans et al., 2011; Hadfield et al., 2008;
Smith et al., 2012b, 2014). Several of the mutant proteins have
been shown to retain some activity (Smith et al., 2012a).
Despite the importance of INI1, little is known about its function.
It is not essential for the assembly of the complex or for its basal
remodeling activity. Analysis of its sequence has not revealed
any obvious functional domains. It participates in a number of
protein-protein interactions involving transcription factors such
as c-MYC and GLI1 as well as transcriptional cofactors (Cheng
et al., 1999; Jagani et al., 2010). Here, we show that theN-terminal
regionof INI1, inwhich the schwannomatosismissensemutations
and in-framedeletions are located, containsahithertounidentified
winged helix DNA binding domain that is also found in metazoan
INI1 homologs and the BAF45a subunit of the PBAF complex.
RESULTS
INI1 and Its Metazoan Homologs Contain a Novel
N-Terminal Domain
Members of the INI1/SNF5 family are all characterized by two
imperfect 60-amino-acid repeats followed by a putative coiled
coil. The region N-terminal to the repeats is more diverse. On
examining the sequence of the N-terminal portion of INI1 we
noted a conserved region, only found in metazoan proteins,
of approximately 100 amino acids that is predicted to be struc-
turedby theprogramJPRED (Cole et al., 2008). Expressionof res-
idues 1–115 of INI1 in Escherichia coli produced a monomeric
protein that gave well-dispersed nuclear magnetic resonance
(NMR) spectra characteristic of a globular protein, confirming
that these residues compose an autonomously folded domain.
Table 1. Summary of Conformational Constraints and Statistics
for the 20 Accepted NMR Structures of the INI1 N-Terminal
Domain
Structural Constraints
Intra-residue 963
Sequential 549
Medium-range (2% ji  jj% 4) 361
Long-range (ji  jj > 4) 576
Dihedral angle constraints 30
TALOS constraints 162
Distance constraints for 42 hydrogen bonds 84
Total 2,725
Statistics for Accepted Structures
Statistical parameters (±SD)
Rmsd for distance constraints (A˚) 0.0083 ± 0.0007
Rmsd for dihedral constraints () 0.471 ± 0.031
Mean CNS energy term (±SD) (kcal mol1)
E (overall) 117.26 ± 8.49
E (van der Waals) 34.13 ± 2.96
E (distance constraints) 13.26 ± 2.32
E (dihedral and TALOS constraints) 5.20 ± 0.68
Rmsd from the ideal geometry (±SD)
Bond lengths (A˚) 0.0014 ± 0.0001
Bond angles () 0.322 ± 0.0080
Improper angles () 0.235 ± 0.013
Average atomic rmsd from the mean structure (±SD) (A˚)
Residues 717–785 (N, Ca, C atoms) 0.376 ± 0.139
Residues 717–785 (all heavy atoms) 0.874 ± 0.121
rmsd, root-mean-square deviation.To determinewhether this domain is present in other proteins, we
undertook a detailed sequence profile search using the PSI-
BLAST program (Altschul et al., 1997). Using residues 10–110 of
INI1 as the query sequence recovered, in addition to INI1 homo-
logs from animals, a region of BAF45a (also known as PHF10),
another subunit of the human SWI/SNF complex (e = 106, itera-
tion 4). A reciprocal search with this portion of BAF45a retrieved
the N-terminal domain of INI1 and metazoan INI1-like proteins.
BAF45a is a member of a family of mutually exclusive SWI/SNF
subunits (BAF45a, b, c, d), unique to metazoans, all of which
contain tandemPHDfingersat theirC termini.Complexescontain
BAF45a appear to be associatedwith dividing cells, during neural
development; for example, BAF45a is switched for BAF45b or
BAF45c as proliferating neural stem and progenitor cells transi-
tion into post-mitotic neurons (Lessard et al., 2007). The region
ofBAF45asimilar in sequence to INI1 isN-terminal to thePHDdo-
mains and is not found in other family members. It is part of the
SAY domain, so named because it was first identified in the
Drosophila BAF45a homolog SAYP (Shidlovskii et al., 2005).
The INI1 N-Terminal Domain Has a DHD-like Winged
Helix Fold
To learnmore about this domain, we determined its structure us-
ing NMR spectroscopy (Table 1). An overlay of the backbonetraces of the 20 lowest-energy structures along with a cartoon
representation of a representative structure are shown in Fig-
ure 1B. Residues 10–110 of INI1 form a compact bbaababaa
fold in which the strands are hydrogen bonded in the order
b1-b2-b4-b3. Helices 1, 2, 4, and 5 pack onto one side of the
sheet and helix 3 packs onto the other side. The structure is
well defined except for the loop between helix 3 and strand 4,
which 1H,15N-NOE (nuclear Overhauser effect) measurements
show is highly mobile (Figure S1). Comparing the structure with
known structures using the program DALI (Holm and Rose-
nstrom, 2010) revealed significant similarities to the dachshund
homology domain (DHD) of SnoN (Z score of 6.2). The SnoN
domain is a member of a family of structurally related domains
found exclusively in metazoan chromatin-associated proteins
that includes the DHD domains of DACH1 and the SKI proto-
oncogene (Kim et al., 2002; Nyman et al., 2010; Wilson et al.,
2004) aswell as domains in theBCL6 co-repressor BCOR (Junco
et al., 2013) and DNTTIP1, a subunit of the HDAC1:MIDEAS co-
repressor complex (Itoh et al., 2015). The INI1 N-terminal domain
also shows significant structural similarity to the winged helix
DNA binding domain of the Mbp1 family of yeast cell cycle reg-
ulatory proteins (Taylor et al., 1997; Xu et al., 1997). Winged helix
domains are found in many DNA binding proteins and are char-
acterized by a helix-turn-helix motif followed by a b hairpin with
the loop connecting the strands of the b hairpin constituting
the wing, ‘‘W.’’ The Mbp1 ortholog from Magnaporthe oryzae
binds to DNA in a manner typical of winged helix domains (Clark
et al., 1993), with the second helix of the helix-turn-helix motif
inserting into the major groove of DNA and residues in the
wing interacting with the minor groove (Figure 3C) (Liu et al.,
2015). In the INI1 domain the first two helices correspond to
the helix-turn-helix motif, with strands 3 and 4 being equivalent
to the hairpin. The INI1, SnoN/DACH1/Ski, BCOR, and DNTTIP1
domains differ from most winged helix domains by having an
additional helix in the loop that forms the wing.
Conserved Residues Map to a Putative Nucleic Acid
Binding Site
A structure-based alignment of the N-terminal domains of INI1
homologs from a range of metazoan species is shown in Fig-
ure 2A. Many residues are invariant in proteins from humans to
Caenorhabditis elegans. Some of these are buried hydrophobic
residues, and others are glycines or proline residues in turns
that also appear to be conserved for structural reasons. Several
of the conserved residues, however, are solvent exposed and
are likely to be functionally important. Most of these are in re-
gions of the protein that interact with DNA in other winged helix
domains (Figure 2C). These include Arg40 and Lys45 in the helix
that in the Mbp1 DNA complex structure inserts into the major
groove of DNA, Arg37 in the loop that precedes it, and Arg52
in the hairpin that follows it. Two residues, Ser30 and Glu31 in
h1, which also contact DNA in the complex structure, are also
completely conserved. Residues Thr56 and Thr88, which are at
the beginning and end, respectively, of the loop that acts as
the wing, are also highly conserved and only begin to be
substituted with serine in some invertebrate INI1 homologs (Fig-
ure 2A). A structure-based alignment of the sequences of the
BAF45a domain from the same species is shown in Figure 2B. In-
sertions and deletions are restricted to loops at the periphery ofStructure 23, 1344–1349, July 7, 2015 ª2015 The Authors 1345
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Figure 1. Structure of the N-Terminal
Domain of INI1
(A) Schematic representation of the domain orga-
nization of INI1 and BAF45a/PHF10.
(B) Superposition of the backbone traces of resi-
dues 10–110 of the 20 lowest-energy structures of
the INI1 N-terminal domain (left) and a ribbon dia-
gram of a representative structure (right).
(C) Comparison of the structures of, from left to
right, the INI1 N-terminal domain, the DHD domain
of SnoN, and Mbp1.the fold, and many of the residues that make up the hydrophobic
cores of the INI1 domain are conserved or replaced with other
hydrophobic residues, suggesting that that the structure of the
BAF45a domain is very similar to that of the INI1 domain. Several
of the solvent-exposed residues conserved in INI1 are also
conserved in the BAF45a domain, especially in helix 2 and in
the first strand of the hairpin, suggesting that it may have a
similar function.
The INI1 N-Terminal Domain Binds dsDNA
The finding that many conserved residues map to the site used
by other winged helix domains to interact with DNA suggested
that the INI1 domain might have a similar function. As the
sequence preference, if any, of the INI1 domain has not been es-
tablished, we decided to test whether it could interact with a
generic double-stranded (ds)DNA sequence by recording 2D
BEST-TROSY spectra of 15N-labeled protein in the presence
and absence of a palindromic DNA oligonucleotide. Addition of
the oligonucleotide produces large changes in the chemical shift
of a subset of residues (Figure 3A). Analysis of the dependence of
the changes in chemical shift on the amount of oligonucleotide
added shows that the bound and free peaks are in fast exchange
on the NMR timescale, and gives an estimate of the dissociation
constant in the high micromolar range which is similar to that
seen for non-sequence-specific DNA interaction of proteins
with this fold. A number of residues undergo especially large
changes in chemical shift, and these are mapped onto a cartoon
representation of the fold of the domain in Figure 3B. These res-
idues include several in the helix predicted to insert into themajor
groove of the DNAbased on theMbp1 complex structure, aswell
as residues in the hairpin and wing regions that are expected to
bind to the minor groove. Large changes in chemical shift are
also observed for residues in the first helix, which is predicted1346 Structure 23, 1344–1349, July 7, 2015 ª2015 The Authorsto interact with the phosphate backbone
of the DNA. These data suggest that the
INI1 domain binds to dsDNA in a manner
similar to that seen for other winged helix
domains.
Disease-Causing Mutations Either
Disrupt the Fold of the Domain or
Locate to the DNA Binding Site
Germline mutations in the gene coding for
INI1 are found in approximately 50% of in-
herited cases of schwannomatosis (Smith
et al., 2014). The most common missensemutation is P14H (Boyd et al., 2008; Hadfield et al., 2008). Pro14
is in a region of extended strand that precedes the first b strand.
The side chain of this residue, which is highly conserved, inter-
acts with the side chains of hydrophobic residues in helices 1
and 4 (Figure 4A). Replacement of proline with a histidine at
this position will disrupt these interactions and is expected to
destabilize the domain. The missense mutations P48L and
R53L have also been identified in familial schwannomatosis
(Boyd et al., 2008; Christiaans et al., 2011). These residues,
which are also highly conserved, are within the DNA binding
site. Pro48 is in a turn at the end of helix 2 (Figure 4B). Replace-
ment of this residue with a leucine would be expected to alter the
conformation of this part of the protein. Arg53 is in the first strand
of the b hairpin that forms the wing (Figure 4C). This residue is on
the surface of the protein close to residues that change chemical
shift upon addition of DNA, suggesting that it could be function-
ally important. The side chain of Arg53 interacts with Glu59 in
helix 3 and thus may also contribute to the stability of the fold.
Attempts to express the Arg53Leu mutant unsuccessfully sug-
gested that the loss of this interaction destabilizes the fold of
the domain. Amutation that changes amino acid 31 from a gluta-
mate to a valine has also been identified in patients with familial
schwannomatosis; however, it appears that the pathogenic
impact of this mutation results from an alteration in mRNA
splicing (Bacci et al., 2010). Glu31 is in helix 1 and is also pre-
dicted to be involved in ligand binding, and it is likely that this
substitution would also be deleterious to the function of the
domain. An in-frame deletion that removes residues 29 and 30
has been linked to familial schwannomatosis (Smith et al.,
2014). These residues are at the N terminus of helix 1, and their
deletion would be expected to be highly destabilizing.
Missense mutations have also been identified in sporadic
schwannomatosis; it is not clear whether a particular substitution
AB
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Figure 2. Sequence Conservation in the INI1 and BAF45a Domains
(A) Sequence alignment of the N-terminal winged helix domains of INI1 homologs from representative species. The secondary structure of the domain is shown
above the sequences, with sheets and helices indicated by arrows and cylinders. Species abbreviations:Hs,Homo sapiens;Gg,Gallus gallus; Xl, Xenopus laevis;
Dr, Danio rerio; Ce, Caenorhabditis elegans. The numbering is for the human protein. Residues mutated in familial schwannomatosis are indicated by green
triangles. Residues mutated in sporadic disease are indicated with gray triangles. Residues that undergo large changes in chemical shift upon DNA binding are
colored red.
(B) Structure-based alignment of the homologous domain in BAF45a proteins from the same species. The sequence and secondary structure of the INI1 domain
are shown below the alignment.
(C) Cartoon representation of the INI1 N-terminal domain, with the side chains of highly conserved residues shown as sticks.is pathogenic (Smith et al., 2012b). One of these mutations also
affects Pro14, in this case replacing it with a serine. This substi-
tution should also be expected to destabilize the protein, and it is
clear that this mutation causes disease. A mutation that changes
Gly29 in helix 1 to an arginine has also been associated with spo-
radic disease. This is predicted to be close to the DNA binding
site, and the substitution of glycine for arginine at this position
is likely to be functionally deleterious.
DISCUSSION
The appearance of a variant winged helix domain in both INI1
and BAF45a is presumably the result of the need for more intri-
cate regulation of the SWI/SNF complex as it began to direct
complex gene expression programs during the development
of multi-cellular animals. The finding that structurally related
domains are also present in a number of other metazoan chro-
matin-associated proteins suggests that domains with this foldmay have a conserved role related to some aspect of chromatin
biology. The data presented here argue strongly that the INI1
domain has a function involving binding to DNA. A sequence-
specific DNA binding role appears to be unlikely, as the SWI/
SNF complex is thought to be directed to specific sites within
the genome by interacting with transcription factors. It is more
probable that, as has been proposed for the homologous
domain from DNTTIP1 (Itoh et al., 2015), it acts as a chromatin
binding module, perhaps only binding with high affinity to DNA
within a particular chromatin environment. Crosslinking studies
of yeast SWI/SNF nucleosome complexes have shown that the
INI1 homolog SNF5, which does not contain the winged helix
domain, associates with the histone octamer and not with nucle-
osomal DNA (Dechassa et al., 2008). Assuming that the overall
architecture of the complex is conserved in metazoa, the INI1
winged helix domain could be positioned to interact with DNA
either in the bound nucleosome or in adjacent sequences. These
interactions might be required for optimal remodeling activity orStructure 23, 1344–1349, July 7, 2015 ª2015 The Authors 1347
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Figure 3. Binding of the INI1 Domain to
dsDNA
(A) 1H,15N-BEST-TROSY spectra of the INI1
domain free (black) and bound to a dsDNA oligo-
nucleotide (red). Residues that undergo particular
large changes in chemical shift upon DNA binding
are indicated.
(B) Cartoon representation of the INI1 N-terminal
domain, with the side chains of residues that
undergo large changes in chemical shift shown as
sticks and colored red.
(C) Cartoon representation of PCG2, the Magna-
porthe oryzae ortholog ofMbp1, bound to its target
DNA sequence.for the complex to act at particular regulatory elements. Perhaps
it is the loss of these types of function that leads to disease. The
data reported here provide a starting point for further efforts to
establish the role played by this domain both in the SWI/SNF
complex and other chromatin-associated proteins, and howmu-
tations that disrupt its function cause disease.
EXPERIMENTAL PROCEDURES
The DNA encoding the first 115 residues of human INI1 was amplified from hu-
man cDNA by PCR and cloned into amodified pRSETA (Invitrogen) expression
vector that produces proteins fused to the N-terminally His6-tagged lipoyl
domain of Bacillus stearothermophilus dihydrolipoamide acetyltransferase.
The resulting plasmids were transformed into E. coli C41 (DE3) cells. Cells
were grown in 2XTY media at 37C to mid-log phase and induced with
1 mM isopropyl b-D-1-thiogalactopyranoside. The temperature was reduced
to 22C and the cells were grown for a further 16 hr. Isotopically labeled do-
mains were prepared by growing cells in K-MOPS minimal media containing
15NH4Cl and/or [
13C]glucose. Cells where lysed by sonication, and the fusion
protein was purified by Ni2+-NTA affinity chromatography and then dialyzedA B
P14*
C
P48*
R53*
Y35 V32
L100
M27
I28
Y47
R46
K45
E59
1348 Structure 23, 1344–1349, July 7, 2015 ª2015 The Authorsovernight in the presence of TEV protease, which
cleaves the fusion protein after the lipoyl domain.
A second Ni2+-NTA affinity chromatography step
was carried out to remove the lipoyl domain, and
the IN11 domain was further purified by gel filtra-
tion using a HiLoad 26/60 Superdex 75 column
(GE Healthcare). The elution volume of the domain
was consistent with it being monomeric.
NMR Measurements
NMR measurements were made using either a
Bruker DRX800 or DRX600 spectrometer equip-
ped with triple-resonance cryoprobes at 25C.
NMR samples were typically 1.5 mM in 90% H2O, 10% D2O, containing
20 mMpotassium phosphate (pH 6.5), 100 mMNaCl, and 5 mM b-mercaptoe-
thanol. Assignments were obtained using standard NMR methods. Heteronu-
clear NOE spectra were obtained using the standard Bruker pulse program.
Structure Determination
Distance restraints were obtained from the analysis of 2D and 3DNOE spectra.
Backbone phi/psi dihedral angle restraints were obtained from chemical shifts
using TALOS+ (Shen et al., 2009). The three-dimensional structures of the INI1
domain were calculated using the standard torsion angle dynamics-simulated
annealing protocol in the program CNS 1.2 (Brunger, 2007). Structures were
accepted where no distance violation was >0.25 A˚ and no dihedral angle
violation >5. Figures were made with the program PyMOL (Schro¨dinger).
The coordinates and the NMR restraints have been deposited in the PDB
with the codes PDB: 5aj1 and r5aj1mr, respectively.
DNA Binding Experiments
Chemical shift perturbation analysis was used to characterize the interaction of
the INI1 winged helix domain and dsDNA. A 15N-labeled INI1 winged helix
domain sample was titrated with unlabeled 24-bp dsDNA. A palindromic
oligonucleotide 50-GGAATTGTGAGCGCTCACAATTCC-30 was chemicallyFigure 4. Residues Mutated in Familial
Schwannomatosis
Close-up views of the INI1 N-terminal domain
showing the positions of Pro14 (A), Pro48 (B) and
Arg53 (C). The mutated residues are indicated with
an asterisk.
synthesized (Integrated DNA Technologies), heated to 98C for 10 min, and
annealed at room temperature to form dsDNA. 1H,15N-BEST-TROSY spectra
of the INI1 domain were collected at each point of the titration to monitor
changes in 1H and 15N resonance frequencies of the domain induced by
dsDNA binding.
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